REFRAME RPD Post-Market Clinical Study

NCT03198520 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 46

Last updated 2020-11-19

Study results available
· View outcomes & findings →

Summary

To evaluate the change in patient Oral Health-related Quality of Life (OHRQoL) from wearing a cobalt chrome (CoCr) removable partial denture (RPD) to wearing the Solvay Dental 360TM polymer Removable Partial Denture (RPD) for 8 weeks.

Conditions

  • Missing Teeth
  • Dental Wear

Interventions

DEVICE

Solvay Dental 360™

polymer Removable Partial Denture (RPD)

Sponsors & Collaborators

  • Solvay Dental 360

    lead INDUSTRY

Principal Investigators

  • Brian Natress, DDS · Leeds School of Dentistry

  • Jiyeon Kim, DDS · University of Illinois Chicago

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-06-06
Primary Completion
2019-10-07
Completion
2019-10-07
FDA Device
Yes

Countries

  • United States
  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03198520 on ClinicalTrials.gov